In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device

NCT05300191 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-09-21

No results posted yet for this study

Summary

A proof-of-concept study of a prototype CloudCath device designed to detect peritonitis using the effluent dialysate from patients undergoing peritoneal dialysis.

Conditions

Interventions

DIAGNOSTIC_TEST

Effluent dialysate

Effluent dialysate samples evaluated for evidence of peritonitis

Sponsors & Collaborators

  • CloudCath

    lead INDUSTRY

Principal Investigators

  • Ben Briggs, MD, PhD · University of California, San Francisco

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300191 on ClinicalTrials.gov